Veru reports cancer drug has high potential to reduce Covid-19 deaths
February 08, 2021 at 20:13 PM EST
Dr. Mitchell Steiner, chief executive of drugmaker Veru, said a Phase 2 trial of VERU-111 showed an 82% relative reduction in Covid-19 patient mortality versus placebo.
